Inventor
PEDRAM BIJAN
US18 patents
⚠️ This page may combine multiple inventors who share the name “PEDRAM BIJAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIGAND PHARM INC
12 patentsUS7071205B2Jul 4, 2006
5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
LIGAND PHARM INC26 citations92
US10030034B2Jul 24, 2018
Heterocycle amines and uses thereof
LIGAND PHARM INC5 citations82
US11186593B2Nov 30, 2021
Heterocycle amines and uses thereof
LIGAND PHARM INC1 citations71
US10604533B2Mar 31, 2020
Heterocycle amines and uses thereof
LIGAND PHARM INC1 citations71
US11773110B2Oct 3, 2023
Heterocycle amines and uses thereof
LIGAND PHARM INC0 citations61
US9266874B2Feb 23, 2016
Heterocycle amines and uses thereof
LIGAND PHARM INC2 citations61
US11413274B2Aug 16, 2022
Methods and compositions associated with the granulocyte colony-stimulating factor receptor
LIGAND PHARM INC0 citations59
US9622991B2Apr 18, 2017
Hematopoietic growth factor mimetic small molecule compounds and their uses
LIGAND PHARM INC1 citations49
US10736875B2Aug 11, 2020
Methods and compositions associated with the granulocyte colony-stimulating factor receptor
LIGAND PHARM INC0 citations48
US10111859B2Oct 30, 2018
Methods and compositions associated with the granulocyte colony-stimulating factor receptor
LIGAND PHARM INC0 citations47
US9492430B2Nov 15, 2016
Methods and compositions associated with the granulocyte colony-stimulating factor receptor
LIGAND PHARM INC0 citations47
US7163946B2Jan 16, 2007
5-substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compounds
LIGAND PHARM INC0 citations41
NOVIRA THERAPEUTICS INC
3 patentsUS10196351B2Feb 5, 2019
Sulfide alkyl compounds for HBV treatment
NOVIRA THERAPEUTICS INC1 citations70
US9597332B2Mar 21, 2017
Sulfide alkyl compounds for HBV treatment
NOVIRA THERAPEUTICS INC1 citations60
US10710959B2Jul 14, 2020
Sulfide alkyl compounds for HBV treatment
NOVIRA THERAPEUTICS INC0 citations49